Commercialization Readiness The company recently secured Series E financing signaling readiness to move toward broader commercialization, presenting opportunities for scalable manufacturing partnerships, distribution deals, and field-ready product launches.

Resource-Light Model With a very small team, HDL Therapeutics is well positioned to engage contract manufacturers, regulatory consultants, and quality systems providers to accelerate development without building in-house operations.

Digital Optimization Their tech stack includes WordPress, Google Analytics and a modern web setup; there is an opportunity to offer digital marketing upgrades, lead capture, partner portals, and CRM/marketing automation to grow inquiries and shorten sales cycles.

Regional MedTech Access Located in New Jersey with access to the NYC metro medical ecosystem, there are channels to engage regional hospitals, academic centers, and distributors for early pilots, trials, and channel partnerships.

Strategic Partnerships Given the size and funding stage, HDL Therapeutics could explore licensing, co-development, or OEM partnerships with larger medtech firms to scale distribution, manufacturing capacity, and go-to-market reach.